Integene International

Integene International Overview

Founded 2010
Status Private
Latest Deal Type Accelerator/​Inc
Latest Deal Amount $300K
Latest Deal Amount
Investors 2

Integene International General Information


Developer of a platform technology intended to treat vascular diseases. The company's technology is developed for the treatment of cardiovascular ischemic disease using combinations of gene and stem cell procedures, enabling patients suffering from vascular diseases gets the required treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 1951 North West 7th Avenue
  • Suite 300
  • Miami, FL 33136
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Integene International Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 13-Aug-2014 $300K 00000 Completed Generating Revenue
2. Angel (individual) Completed Startup
1. Grant $10M Completed Startup

Integene International Executive Team (3)

Name Title Board Seat Contact Info
Keith Webster Ph.D Founder, President & Chief Executive Officer
Michael Gold Executive Chairman

1 Former Executive

Integene International Board Members (3)

To view Integene International‘s full board member team, request access »
Name Representing Role Since
Eduardo De Marchenna MD Integene International Board Member 000 0000
Michael Gold Integene International Executive Chairman 000 0000

1 Former Board Member

Integene International Investors (2)

To view Integene International‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Florida Institute for the Commercialization of Public Research Not-For-Profit Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0

Ready to get started?

Request a free trial